Cargando…
Correction: Programmed death ligand 1-positive immune cells in primary tumor or metastatic axillary lymph nodes can predict prognosis of triple-negative breast cancer even when present at < 1% in the tumor region
Autores principales: | Tomioka, Nobumoto, Hatanaka, Kanako C., Okuyama, Dai, Watanabe, Ken-ichi, Yamamoto, Mitsugu, Maeda, Hideki, Tachikawa, Hanae, Kuwahara, Sayuri, Shimizu, Ai, Suzuki, Hiroaki, Hatanaka, Yutaka, Takahashi, Masato |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Nature Singapore
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10284968/ https://www.ncbi.nlm.nih.gov/pubmed/37103743 http://dx.doi.org/10.1007/s12282-023-01454-5 |
Ejemplares similares
-
Programmed death ligand 1-positive immune cells in primary tumor or metastatic axillary lymph nodes can predict prognosis of triple-negative breast cancer even when present at < 1% in the tumor region
por: Tomioka, Nobumoto, et al.
Publicado: (2023) -
Clinical Management of Potential Toxicity of Abemaciclib and Approaches to Ensure Treatment Continuation
por: Takada, Shinya, et al.
Publicado: (2023) -
p53 accumulation is a strong predictor of recurrence in estrogen receptor-positive breast cancer patients treated with aromatase inhibitors
por: Yamamoto, Mitsugu, et al.
Publicado: (2014) -
Predicting the Efficacy and Safety of TACTICs (Tumor Angiogenesis-Specific CAR-T Cells Impacting Cancers) Therapy for Soft Tissue Sarcoma Patients
por: Fujiwara, Kento, et al.
Publicado: (2020) -
Genetic heterogeneity during breast cancer progression in young patients
por: Hagio, Kanako, et al.
Publicado: (2021)